{"id":49567,"date":"2022-10-13T08:01:42","date_gmt":"2022-10-13T06:01:42","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\/"},"modified":"2022-10-13T08:01:42","modified_gmt":"2022-10-13T06:01:42","slug":"galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\/","title":{"rendered":"Galderma Announces Intention to Expand Manufacturing and Innovation Footprint in Asia-Pacific"},"content":{"rendered":"<div>\n<ul class=\"bwlistdisc\">\n<li>\nGalderma, the pure-play dermatology category leader, announces its intention to explore opportunities to build its fifth manufacturing plant in Singapore\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li>\nSupported by the Singapore Economic Development Board, the new facility is expected to increase Galderma\u2019s manufacturing capacity by up to 350 million units per year, in response to continuing demand for premium science-based products in the Dermo-cosmetics sector\n<\/li>\n<\/ul>\n<p>ZUG, Switzerland&#8211;(BUSINESS WIRE)&#8211;Reaffirming its bold ambition to become the leading dermatology company in the world, Galderma today announced its intention to expand its manufacturing and innovation footprint in the Asia-Pacific region, with support from the Singapore Economic Development Board. Galderma intends to explore opportunities to build a fifth manufacturing plant with a high degree of digitalization and automation in Singapore in response to growing consumer demand and to support long-term sustainable growth over the coming years.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221012005570\/en\/1599610\/5\/DSC08984.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221012005570\/en\/1599610\/21\/DSC08984.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20221012005570\/en\/1599609\/5\/GALDERMA_LOGO_BLACK_RGB.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221012005570\/en\/1599609\/21\/GALDERMA_LOGO_BLACK_RGB.jpg\"><\/a><\/p>\n<p>\nThe announcement comes as part of Galderma\u2019s strategic manufacturing roadmap, aligned with the company\u2019s unique Integrated Dermatology Strategy. Following a record 2021 performance, Galderma has demonstrated strong commercial and financial performance in the first half of 2022, with continued strong growth across product categories. In particular, Dermo-cosmetics has grown by 31% year-on-year on a constant currency basis, fueled by the strong performance of Cetaphil\u00ae driven by e-commerce and launches in China and the rest of Asia.\n<\/p>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignc\">\n<tr>\n<td class=\"bwvertalignt bwpadl0 bwrowaltcolor0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwalignc bwcellpmargin\">\n\u201cOur goal is to support our strong growth trajectory in the long-term with a new manufacturing plant that will significantly increase our capacity to serve consumers with premium brands from our differentiated Dermo-cosmetics portfolio across geographies, and primarily throughout our key markets in Asia-Pacific. We sincerely thank the Economic Development Board of Singapore for its support, and we look forward to further collaboration to bring this exciting project to life.\u201d<br \/>\n\n<\/p>\n<p class=\"bwalignc bwcellpmargin\">\n<b>FLEMMING \u00d8RNSKOV, M.D., MPH<br \/>\n<br \/><\/b><b>CHIEF EXECUTIVE OFFICER<br \/>\n<br \/><\/b><b>GALDERMA<\/b>\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p>\nWith its premiumization strategy and broad channel exposure, Galderma is well positioned to capitalize on growing consumer demand across Asia-Pacific, where the compelling dermatology market has remained on a consistent growth trajectory, with robust demand for premium science-based products. Galderma\u2019s new manufacturing plant in Singapore is expected to increase the company\u2019s total capacity for Dermo-cosmetics premium brand production by up to 350 million units a year, in line with anticipated growth in the region.\n<\/p>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignc\">\n<tr>\n<td class=\"bwvertalignt bwpadl0 bwrowaltcolor0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwalignc bwcellpmargin\">\n\u201cWe welcome Galderma&#8217;s expansion in Singapore, driven by the need to meet growing demand and sophistication of consumers in Asia. This adds to the growing number of consumer healthcare companies that use Singapore as a hub for innovation. We are also pleased that Galderma&#8217;s first Dermo-cosmetics manufacturing plant in Asia will be landing in Singapore, as it will leverage and contribute to Singapore&#8217;s advanced manufacturing capabilities. There will be many exciting innovation and manufacturing job opportunities that Galderma will create with this investment.\u201d<br \/>\n\n<\/p>\n<p class=\"bwalignc bwcellpmargin\">\n<b>MR TAN KONG HWEE<br \/>\n<br \/><\/b><b>EXECUTIVE VICE PRESIDENT<br \/>\n<br \/><\/b><b>ECONOMIC DEVELOPMENT BOARD<\/b>\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p>\nGalderma already benefits from a well-established presence in Singapore, which is not only a key market for Galderma\u2019s innovative portfolio of cutting-edge brands and services, but also serves as its Asia-Pacific regional hub.\n<\/p>\n<p>\n<b>About Galderma<br \/>\n<br \/><\/b>Galderma is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that spans the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermo-cosmetics and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body\u2019s largest organ \u2013 the skin \u2013 meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we\u2019re in shapes our lives, we are advancing dermatology for every skin story.\n<\/p>\n<p>\nFor more information: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.galderma.com&amp;esheet=52942721&amp;newsitemid=20221012005570&amp;lan=en-US&amp;anchor=www.galderma.com&amp;index=1&amp;md5=6e191a3e2c097ee73009930ade4eb545\" rel=\"nofollow noopener\" shape=\"rect\">www.galderma.com<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>For further information:<\/b><br \/>Christian Marcoux, M.Sc.<br \/>\n<br \/>Chief Communications Officer<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;&#x74;o&#58;&#x63;&#x68;&#x72;i&#115;&#x74;&#x69;&#x61;n&#46;&#x6d;&#x61;&#x72;c&#111;&#x75;&#x78;&#x40;g&#97;&#x6c;&#x64;&#x65;r&#109;&#x61;&#x2e;&#x63;o&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#99;&#x68;&#x72;i&#115;&#x74;i&#97;&#x6e;&#x2e;m&#97;&#x72;c&#111;&#x75;&#x78;&#64;&#103;&#x61;l&#100;&#x65;&#x72;&#109;&#97;&#x2e;c&#111;&#x6d;<\/a><br \/>+41 76 315 26 50\n<\/p>\n<p>\nS\u00e9bastien Cros<br \/>\n<br \/>Corporate Communications Director<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;t&#111;&#x3a;&#x73;e&#98;&#x61;&#x73;t&#105;&#x65;&#x6e;&#46;&#99;&#x72;&#x6f;s&#64;&#103;&#x61;&#x6c;d&#101;&#x72;&#x6d;a&#46;&#x63;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x73;&#101;&#x62;&#97;s&#x74;&#105;e&#x6e;&#46;&#x63;&#x72;o&#x73;&#64;g&#x61;&#108;&#x64;&#x65;r&#x6d;&#97;&#46;&#x63;&#111;m<\/a><br \/>+41 79 529 59 85\n<\/p>\n<p>\nTracy Krumme<br \/>\n<br \/>Global Head of Investor Relations<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#108;&#116;&#111;:i&#x6e;&#x76;&#x65;&#x73;&#116;&#111;rs&#x40;&#x67;&#x61;&#x6c;&#100;&#101;rm&#x61;&#x2e;&#x63;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x69;&#x6e;&#118;e&#x73;&#x74;&#x6f;&#114;s&#x40;&#x67;&#x61;&#108;d&#x65;&#x72;&#x6d;&#97;&#46;&#x63;&#x6f;&#x6d;<\/a><br \/>+1-817-961-5530\n<\/p>\n<p>\nLaurent de Weck<br \/>\n<br \/>Investor Relations Senior Manager<br \/>\n<br \/><a target=\"_blank\" href=\"mailto:laurent&#46;deweck&#64;ga&#108;&#100;&#101;&#114;&#109;&#97;&#46;&#99;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">la&#117;&#114;&#x65;&#x6e;&#x74;&#x2e;de&#119;&#101;&#x63;&#x6b;&#x40;&#x67;al&#100;&#101;&#114;&#x6d;&#x61;&#x2e;&#x63;om<\/a><br \/>+41 58 515 38 57\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Galderma, the pure-play dermatology category leader, announces its intention to explore opportunities to build its fifth manufacturing plant in Singapore Supported by the Singapore Economic Development Board, the new facility is expected to increase Galderma\u2019s manufacturing capacity by up to 350 million units per year, in response to continuing demand for premium science-based products in &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49567","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Galderma Announces Intention to Expand Manufacturing and Innovation Footprint in Asia-Pacific - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Galderma Announces Intention to Expand Manufacturing and Innovation Footprint in Asia-Pacific - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Galderma, the pure-play dermatology category leader, announces its intention to explore opportunities to build its fifth manufacturing plant in Singapore Supported by the Singapore Economic Development Board, the new facility is expected to increase Galderma\u2019s manufacturing capacity by up to 350 million units per year, in response to continuing demand for premium science-based products in ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-13T06:01:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221012005570\/en\/1599610\/21\/DSC08984.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Galderma Announces Intention to Expand Manufacturing and Innovation Footprint in Asia-Pacific\",\"datePublished\":\"2022-10-13T06:01:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\\\/\"},\"wordCount\":657,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221012005570\\\/en\\\/1599610\\\/21\\\/DSC08984.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\\\/\",\"name\":\"Galderma Announces Intention to Expand Manufacturing and Innovation Footprint in Asia-Pacific - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221012005570\\\/en\\\/1599610\\\/21\\\/DSC08984.jpg\",\"datePublished\":\"2022-10-13T06:01:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221012005570\\\/en\\\/1599610\\\/21\\\/DSC08984.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221012005570\\\/en\\\/1599610\\\/21\\\/DSC08984.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Galderma Announces Intention to Expand Manufacturing and Innovation Footprint in Asia-Pacific\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Galderma Announces Intention to Expand Manufacturing and Innovation Footprint in Asia-Pacific - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\/","og_locale":"en_US","og_type":"article","og_title":"Galderma Announces Intention to Expand Manufacturing and Innovation Footprint in Asia-Pacific - Pharma Trend","og_description":"Galderma, the pure-play dermatology category leader, announces its intention to explore opportunities to build its fifth manufacturing plant in Singapore Supported by the Singapore Economic Development Board, the new facility is expected to increase Galderma\u2019s manufacturing capacity by up to 350 million units per year, in response to continuing demand for premium science-based products in ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-13T06:01:42+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221012005570\/en\/1599610\/21\/DSC08984.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Galderma Announces Intention to Expand Manufacturing and Innovation Footprint in Asia-Pacific","datePublished":"2022-10-13T06:01:42+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\/"},"wordCount":657,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221012005570\/en\/1599610\/21\/DSC08984.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\/","url":"https:\/\/pharma-trend.com\/en\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\/","name":"Galderma Announces Intention to Expand Manufacturing and Innovation Footprint in Asia-Pacific - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221012005570\/en\/1599610\/21\/DSC08984.jpg","datePublished":"2022-10-13T06:01:42+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221012005570\/en\/1599610\/21\/DSC08984.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221012005570\/en\/1599610\/21\/DSC08984.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Galderma Announces Intention to Expand Manufacturing and Innovation Footprint in Asia-Pacific"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49567","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49567"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49567\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49567"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49567"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}